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Missense mutations (K141N and K141E) in the a-crystallin domain of the small heat shock protein HSPB8
(HSP22) cause distal hereditary motor neuropathy (distal HMN) or Charcot-Marie-Tooth neuropathy type 2L
(CMT2L). The mechanism through which mutant HSPB8 leads to a speciﬁc motor neuron disease phenotype
is currently unknown. To address this question, we compared the effect of mutant HSPB8 in primary neuronal
and glial cell cultures. In motor neurons, expression of both HSPB8 K141N and K141E mutations clearly
resulted in neurite degeneration, as manifested by a reduction in number of neurites per cell, as well as in
a reduction in average length of the neurites. Furthermore, expression of the K141E (and to a lesser
extent, K141N) mutation also induced spheroids in the neurites. We did not detect any signs of apoptosis
in motor neurons, showing that mutant HSPB8 resulted in neurite degeneration without inducing neuronal
death. While overt in motor neurons, these phenotypes were only very mildly present in sensory neurons
and completely absent in cortical neurons. Also glial cells did not show an altered phenotype upon
expression of mutant HSPB8. These ﬁndings show that despite the ubiquitous presence of HSPB8, only
motor neurons appear to be affected by the K141N and K141E mutations which explain the predominant
motor neuron phenotype in distal HMN and CMT2L.
INTRODUCTION
Small heat shock proteins (sHSPs) are ubiquitously expressed
conserved stress proteins involved in multiple cellular pro-
cesses (1,2). These stress-induced molecular chaperones are
vital for cell viability since they protect cells against environ-
mental stress during aging, by assisting in the correct folding
of denatured proteins, and by preventing aggregation of mis-
folded proteins (3).
Dominant missense mutations in two sHSPs genes, HSPB8
(HSP22)a n dHSPB1 (HSP27), have been associated with
distal hereditary motor neuropathy (distal HMN MIM#158590)
and Charcot-Marie-Tooth type 2 disease (CMT2L and CMT2F
MIM#158590) (4–6). These neuropathies are clinically and
genetically heterogeneous disorders of the peripheral nervous
system (7). In distal HMN, the motor nerves are predominantly
affected (8), although minor sensory abnormalities have been
described in some families (9–11), explaining the clinical
overlap between distal HMN and CMT2.
We previously reported that missense mutations (K141N
and K141E) in the a-crystallin domain of HSPB8 play an
important role in neurodegenerative disorders (5). Our
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sion mutant HSPB8 formed cytoplasmic protein accumu-
lations, which could sequester other soluble proteins
including HSPB1. We also reported that mutant HSPB8
showed greater binding to the molecular partner HSPB1.
Finally, we speculated that heat shock proteins could be
involved in the formation of the stable neuroﬁlament
network and demonstrated that mutant HSPB1 altered neuroﬁ-
lament assembly (6). We hypothesize that despite the ubiqui-
tous presence and pleiotropic functions of sHSP, there could
be a motor neuron-speciﬁc pathway which would explain the
predominant motor neuron phenotype observed in the distal
HMN patients.
Since all previous studies were done in continuous cell
lines, which might behave very different from primary cells,
we decided to extend our previous results and examined the
effect of mutant HSPB8 protein (K141N and K141E) in
primary glial cells, in peripheral neurons including motor
neuron and dorsal root ganglia (DRG) sensory neuron cultures
and in cortical neurons. We found that mutations in HSPB8
strongly affect neurite length and integrity in motor neurons,
whereas the other cell types were generally unaffected.
Furthermore, degeneration of neurites in motor neurons
seemed to occur independently of apoptosis and death of the
cell body.
These results support the clinical descriptions of distal
HMN type II with predominant involvement of motor
neurons implying that mutant HSPB8 causes speciﬁc defects
in preserving motor neuron axons. Furthermore, this study
provides the ﬁrst evidence that mutant HSPB8 induces
neurite degeneration, which is a sign of axonal neuropathy.
RESULTS
Expression of mutant HSPB8 in primary motor neurons
induces spheroids and shortened neurites
To ﬁnd out if mutations in HSPB8 affect motor neuron viabi-
lity, we studied the expression of the HSPB8 mutations
(K141N and K141E) in primary motor neurons isolated from
spinal cords of Wistar rat embryos. To this end, we used a
highly efﬁcient lentiviral approach which results in stable inte-
gration of the exogenous construct. Both wild-type (WT) and
mutant HSPB8 constructs were transduced with similar efﬁ-
ciencies, yielding highly comparable protein expression
levels (Supplementary Material, Fig. S1A). Furthermore, WT
and mutant HSPB8-GFP fusion proteins showed a similar
localization pattern within the motor neuron with homogenous
distribution in cell body, nucleus and neurites (Supplementary
Material, Fig. S1A). No aggregates could be detected in motor
neurons, which was clearly distinct from earlier studies using
transient transfection approaches (5).
Interestingly, striking differences could be observed when we
compared the morphology of motor neurons transduced with
WT-HSPB8 with those expressing mutant HSPB8, as judged
by SMI32 neuroﬁlament immunostaining. Motor neurons trans-
duced with mutant HSPB8 clearly showed neurites with signs
ofdegeneration,whilethiswasnotthecaseinneuronstransduced
with WT HSPB8 or control constructs (Fig. 1A–E). In cells
expressing the K141N-HSPB8-GFP construct, we observed a
reduction in length of the distal neurites (deﬁned as shortened
neurites in Materials and Methods) in  80% of the mutant
expressingmotorneurons(dataobtainedat4daysaftertransduc-
tion and for three independent experiments; percentage motor
neurons in culture showing shortened neurites: GFP ¼ 17.0+
1.0%, n ¼ 361; WT-HSPB8-GFP ¼ 14.0+2.0%, n ¼ 192;
K141N-GFP ¼ 86.0+3.0%, n ¼ 150, P-value ¼ 2.5 × 10
25
and K141E-GFP ¼ 75.0+3.0%, n ¼ 300, P-value ¼ 8.7 ×
10
26)(Fig.1F).IncellsexpressingtheK141E-HSPB8-GFPcon-
struct, we observed a more severe phenotype consisting of shor-
tened neurites, as well as neurites containing beaded-like
structures resembling spheroids (data of three independent
experiments, percentage of motor neurons showing beaded phe-
notype at day in vitro 7 (DIV7): GFP ¼ 12.0+5.0%, n ¼ 338;
WT-HSPB8-GFP ¼ 0.0+0.0%, n ¼ 192; K141N-HSPB8-
GFP ¼ 9.0+6.0%, n ¼ 150, P-value ¼ 0.1333 and K141E-
HSPB8-GFP ¼ 90.0+1.0%, n ¼ 300, P-value ¼ 4.1 × 10
25)
(Fig. 1G).
To further investigate the integrity of motor neurons expres-
sing HSPB8, we performed extensive quantiﬁcations measur-
ing neurite length and number. Figure 1H illustrates the
distribution of neurite length in different motor neurons. The
mean neurite length of non-transduced motor neurons and
motor neurons expressing either WT-HSPB8-GFP or native
GFP protein was over 800 mm per soma, while the mean
neurite length of motor neurons expressing either K141N or
K141E-HSPB8-GFP protein was signiﬁcantly lower, i.e.
below 350 mm (non-transfected ¼ 824+332 mm, n ¼ 55;
GFP ¼ 804+325 mm, n ¼ 74; WT-HSPB8-GFP ¼ 939+
513 mm, n ¼ 61; K141N-HSPB8-GFP ¼ 233+186 mm,
n ¼ 30, P-value ¼ 1.2 × 10
210 and K141E-HSPB8-GFP ¼
338+177 mm, n ¼ 47, P-value ¼ 8.4 × 10
212). The average
neurite number per motor neuron expressing WT-HSPB8-GFP
was higher than four neurites per soma, whereas the average
neurite number per motor neuron expressing either K141N
or K141E-HSPB8-GFP protein was lower than three neurites
per soma (GFP ¼ 4.5+1.5, n ¼ 248; WT-HSPB8-GFP ¼
4.0+1.5, n ¼ 219; K141N-HSPB8-GFP ¼ 1.6+1.2, n ¼
428, P-value ¼ 1.3 × 10
257 and K141E-HSPB8-GFP ¼
1.1+0.9, n ¼ 424, P-value ¼ 4.5 × 10
274) (Fig. 1I).
These data show that the expression of K141N/K141E-
HSPB8 mutant protein strongly affects neurite integrity,
compared with the WT, resulting in a higher percentage of
motor neurons with neurite abnormalities.
Accumulation of amyloid precursor protein (APP) in
neurites of mutant HSPB8 expressing motor neurons
is a sign of neurite degeneration
To further verify if the neurite degeneration phenotype that we
observed in motor neuron could be a sign of axonal degener-
ation, we used amyloid precursor protein (APP) as a marker
for neurodegeneration. Early studies identiﬁed APP as a
kinesin-binding protein (12,13). APP is a normal component
of neurons transported by fast axonal transport, and speciﬁcally
accumulates to detectable levels at sites where the cytoskeleton
breaks down and therefore can be used as a read-out to study
axonal transport defects (14–16). In healthy neuronal cells
with normal axonal transport rates, APP is rapidly transported,
leading to disperse signals on APP immunostainings. In cells
Human Molecular Genetics, 2010, Vol. 19, No. 16 3255Figure 1. Mutant HSPB8 induces neurite abnormalities in primary motor neurons. Rat motor neurons were transduced with pLenti-GFP,
pLenti-WT-HSPB8-GFP or mutant pLenti-K141N/K141E-HSPB8-GFP constructs at day in vitro 3 (DIV3) and immunostained against the non-phosphorylated
epitope in neuroﬁlament H (SMI32 antibody) at DIV7. Non-transduced motor neurons (A), motor neurons expressing native GFP (B) and WT-HSPB8 (C) show a
punctate and homogenous neuroﬁlament distribution in the motor neuron soma and normal formation of long and intact neurites, while neuritic processes of
motor neurons expressing mutant HSPB8-K141N are shortened (D), and motor neurons expressing mutant HSPB8-K141E exhibited clear signs of neurite
degeneration (spheroids or beaded neurites) (E). Scale bar ¼ 10 mm. The incidence of neurite abnormalities in the motor neuron cultures were quantiﬁed by
counting the proportion of neurons with abnormal (reduced or shortened) neurites (F) and with clear signs of neurite degeneration (beaded neurites) (G),b y
measuring neurite length distribution (H) and by counting the number of neurites per neuron (I). ns ¼ not signiﬁcant, ∗∗P-value , 0.01.
3256 Human Molecular Genetics, 2010, Vol. 19, No. 16with axonal transport defects, APP rapidly accumulates
leading to a strong signal in immunostainings. It is well estab-
lished that defects in axonal transport and neurite degeneration
are strongly linked (17) and therefore we examined this by
immunostaining APP in neurites of motor neurons expressing
either WT or mutant HSPB8 (Fig. 2A and B). Motor neurons
expressing HSPB8-WT showed mostly a faint and punctate
pattern of APP immunostaining indicative of a normal axonal
transport, while strong accumulation of APP was detected in
many neurites of mutant HSPB8 expressing motor neurons
(data of three independent experiments at DIV7: GFP ¼ 12+
1.0%, n ¼ 994; WT-HSPB8-GFP ¼ 12+0.0%, n ¼ 971;
K141N-GFP ¼ 24.5+2.0%, n ¼ 864, P-value ¼ 0.0082 and
K141E-GFP ¼ 25+1.0%, n ¼ 1029, P-value ¼ 0.0019)
(Fig. 2C–E). These data therefore suggest that axonal transport
blockage could be implicated in the development of mutant
HSPB8 associated neurite degeneration.
Expression of mutant HSPB8 does not induce overt
spheroids in neurites of primary sensory or cortical
neurons or in glial cells
To check whether the phenotype we observed in primary
motor neurons was cell type speciﬁc, we investigated if
other cell types both of non-neuronal and neuronal origin,
Figure 2. Motor neurons expressing mutant HSPB8 show enhanced neuritic
APP accumulation. Rat motor neurons were transduced with pLenti-GFP,
pLenti-WT-HSPB8-GFP or mutant pLenti-K141N/K141E-HSPB8-GFP con-
structs at DIV3 and immunostained using amyloid precursor protein (APP)
antibody at DIV7. Motor neuron neurites expressing GFP (A)o r
HSPB8-WT (B) mainly show a faint and punctate appearance of APP in the
neurites, similar to non-transduced neurites, while neurites of motor neuron
expressing HSPB8-K141N (C) or HSPB8-K141E (D) accumulate more APP
(arrow). The incidence of APP accumulation was quantiﬁed by counting the
proportion of cells with strong neuritic APP accumulation (E). ∗∗P-value ,
0.01. Scale bar ¼ 10 mm.
Figure 3. Expression of mutant HSPB8 has no detectable effect on the
morphology of primary glial cells. Rat glial cells were transduced with
pLenti-GFP, pLenti-WT-HSPB8-GFP or mutant pLenti-K141N/K141E-
HSPB8-GFP constructs at DIV3 and immunostained at DIV7 with antibodies
against either GFAP (left) or 2′,3 ′-cyclic nucleotide 3′-phosphodiesterase
(CNPase, right). The glial cells expressing GFP (A), WT-HSPB8 (B),
mutant HSPB8-K141N (C) or HSPB8-K141E (D) were morphologically
similar. Scale bar ¼ 10 mm.
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ation. To this end, we ﬁrst expressed mutant and
WT-HSPB8 in primary glial cells isolated from spinal cords
of Wistar rat embryos. Similarly to neurons, glial cells
appeared to be highly efﬁciently transduced by lentivirus
yielding similar protein expression levels for WT and
mutant constructs (Supplementary Material, Fig. S1B). Of
note is that some glial cells overexpressing mutant HSPB8
constructs showed protein aggregates in the cytoplasm, prob-
ably due to higher expression levels compared with motor
neurons.
However, despite these high expression levels, no gross mor-
phological differences were detected between WT and mutant
HSPB8 expressing cells, as judged by immunostainings with
glial ﬁbrillary acidic protein (GFAP) or 2′,3 ′-cyclic nucleotide
3′-phosphodiesterase (CNPase) antibodies (Fig. 3A–D). All
cells appeared healthy and did not show clear signs of stress
such as changes in cell or nuclear shape or presence of
vacuoles. These data indicate that overexpression of mutant
HSPB8 does not affect glial cells, suggesting a neuron-speciﬁc
toxicity.
To check whether other neuronal cell types were affected in
the same way as motor neurons, we isolated sensory neurons
from DRGs and cortical neurons from brain tissue of C57BL6
mouse E13 and E15 embryos, respectively. Purity of the cul-
tures was conﬁrmed by immunostaining with neuron-speciﬁc
beta III tubulin antibody. Primary neurons were transduced
with WT-HSPB8 or mutant (K141N and K141E)-HSPB8-GFP
fusionconstructs,yieldingsimilarexpressionlevelsofbothWT
andmutantproteins (Supplementary Material, Fig.S1C and D).
The majority of the primary sensory neurons expressing
mutant K141N-HSPB8 appeared healthy and morphologically
similar to WT-HSPB8 or native GFP expressing sensory
neurons (Fig. 4A–C). However, beaded neurites were
observed in  10% of the mutant K141E-HSPB8 expressing
sensory neuronal cells, similarly to what we saw before in
motor neurons, though to a lower extent (10 versus 80%)
(Fig. 4D) (GFP ¼ 0.0+0.0%, n ¼ 655; WT-HSPB8-GFP ¼
0.0+0.0%, n ¼ 436; K141N-GFP ¼ 0.5+0.0%, n ¼ 578,
P-value ¼ 0.221 and K141E-GFP ¼ 9.7+1.9%, n ¼ 660,
P-value ¼ 0.000) (Fig. 4E).
Interestingly, cortical neurons expressing both mutant
HSPB8 proteins were morphologically normal and indistin-
guishable from WT-HSPB8 or native GFP expressing
neurons (Fig. 5A–D). Over 100 cortical neurons expressing
either mutant or WT-HSPB8-GFP constructs were examined
and no beaded or shortened neurites were observed. These
results clearly show that the cellular defects caused by
mutations in HSPB8 are manifested in neuronal cells originat-
ing from the peripheral nervous system and not in cells from
the central nervous system. Furthermore, they appear much
more pronounced in motor neurons compared with sensory
neurons.
Motor neurons expressing mutant HSPB8 show neurite
degeneration without signs of apoptosis in the cell body
Neuronal cell death via apoptosis is often linked to
neurodegenerative diseases (18). Therefore, we evaluated
whether apoptotic pathways were activated in motor neurons
expressing mutant HSPB8 by using a TUNEL assay. This
assay is used for the detection and quantiﬁcation of apoptosis
at single cell level, based on labeling of DNA strand breaks.
Figure 4. Mutant HSPB8 induces neurite degeneration in a small proportion
of primary sensory neurons. Mouse sensory neurons were transduced
with pLenti-GFP, pLenti-WT-HSPB8-GFP or mutant pLenti-K141N/K141E-
HSPB8-GFP constructs at DIV6 and immunostained at DIV10 using b-III
tubulin antibody. Merged confocal micrographs of GFP (green) and b-III
tubulin (red) are shown (A–D). No signs of neurite degeneration were
found in sensory neurons expressing GFP (A), HSPB8-WT (B) and
HSPB8-K141N (C), while the neurites of some cells expressing
HSPB8-K141E were clearly beaded (arrow) (D). Scale bar ¼ 10 mm. The inci-
dence of neurite degeneration was quantiﬁed by counting the proportion of
neurons with beaded neurites (E). ∗∗P-value , 0.01.
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induce apoptosis in transduced motor neuron cultures
(Fig. 6A). An additional internal positive control for the
TUNEL staining was provided by the TUNEL-positive
nuclei of dead cells always present in primary cultures
(arrow heads in Fig. 6).
Asexpected,motorneuronsexpressingWT-HSPB8proteinor
GFP constructs were TUNEL negative (Fig. 6B and C). Interest-
ingly, motor neurons expressing mutant HSPB8-K141E or
HSPB8-K141N protein were equally TUNEL negative, despite
the presence of spheroids and shortened neurites (Fig. 6Da n d
E). Over 100 motor neurons expressing either mutant or
WT-HSPB8-GFP constructs were examined and no link could
be observed between TUNEL-positive cells and mutant
HSPB8 expression. Similarly to motor neurons, neither the
sensory nor the cortical neurons expressing WT-HSPB8 or
mutant HSPB8 protein were TUNEL positive (Supplementary
Material, Figs S2 and S3). Identical results were also observed
in glial cells expressing HSPB8 (data not shown).
To further exclude that expression of mutant HSPB8
induces apoptosis, we investigated the activation status of
apoptotic markers in primary neurons, glial cells and in a neur-
onal cell line (SH-SY5Y) stably expressing WT or mutant
HSPB8. Three well-established apoptotic markers were
evaluated: cleaved caspase 3, cleaved caspase 9 and cleaved
poly (ADP-ribose) polymerase (PARP) (19,20). Conﬁrming
our results obtained with the TUNEL assay, no evidence
of accumulation of these apoptotic markers was detected in
primary motor neurons despite the clear neurite degeneration
phenotype (Fig. 7B). Similarly, no accumulation of
apoptotic markers could be detected in glial cells or in the
stably expressing SH-SY5Y cells (Fig. 7A–C). These results
strongly indicate that the degeneration caused by mutant
HSPB8 is neurite speciﬁc and does not activate classical
apoptotic pathways.
DISCUSSION
An increasing number of ubiquitously expressed genes have
been identiﬁed as the genetic culprits of a number of inherited
peripheral neuropathies (7). Mutations in the small heat shock
proteins HSPB8 (HSP22) have been associated with distal
HMN and CMT2 (1). The HSPB8 mutations target a
hot-spot Lysine residue at position 141 located in the predicted
b7 strand of the conserved a-crystallin domain (21). In distal
HMN patients, the disease phenotype presents ﬁrst with
paresis of the extensor muscles of the feet, which rapidly pro-
gresses to paralysis and weakness of all distal muscles of the
lower extremities within 5 years (7,22,23).
How defects in HSPB8 basic functions could result in motor
neuron degeneration while leaving other tissues unaffected
remains an enigma. Changes in the protein structure of
mutant HSPB8 could result in inefﬁcient quality control activi-
ties (24,25). This, in turn, could reduce the maintenance of
peripheral neuron homeostasis plausibly blocking axonal
transport, which is a common feature in peripheral neuropathy.
To shed some light on this mystery, we studied the effects of
HSPB8 mutant proteins in primary neuronal culture.
The HSPB8 protein is ubiquitously expressed in most cell
types with particularly high levels in muscle and nervous
tissue (5,26). We studied the effect of mutant HSPB8 proteins
in primary glial cells and in three different neuronal cell types:
motor neurons, sensory neurons and cortical neurons. Our
studies demonstrated that lentiviral transduction of mutant
HSPB8 promoted the selective degeneration of motor neuron
neurites while leaving other cell types mostly unaffected.
Motor neurons expressing the K141N-HSPB8 mutation
showed a phenotype consisting of reduced or shortened neur-
Figure 5. Cortical neurons expressing mutant HSPB8 do not show neurite
abnormalities. Mouse cortical neurons were transduced with pLenti-GFP
(A), pLenti-WT-HSPB8-GFP (B), mutant pLenti-K141N-HSPB8-GFP (C)
or pLenti-K141E-HSPB8-GFP (D) constructs at DIV3 and immunostained
with b-III tubulin at DIV7. Merged confocal micrographs of GFP (green)
and b-III tubulin (red) are shown. Expression of the different HSPB8 con-
structs did not result in abnormal neurite formation. Scale bar ¼ 10 mm.
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neurons expressing the K141E-HSPB8 mutation showed a
more pronounced phenotype consisting of shortened neurites
as well as neurites that were disﬁgured by a series of regularly
spaced, coarse dilatations, which we refer to as spheroids or
beaded neurites. Since we did not follow particular neurites
over time, we cannot claim at this stage whether the phenotype
of the shortened neurites is caused by retraction or by lack of
growth. However, since we also observed the presence of
beaded neurites, which is a well-established marker of
axonal degeneration (16), we consider our present results
indicative of retraction rather than a lack of outgrowth. Inter-
estingly, DRG sensory neurons expressing the K141N-HSPB8
did not exhibited any obvious morphological phenotype,
whereas the K141E-HSPB8 mutation showed very mild
neurite degeneration with only 10% of the neurites being
affected. Cortical neurons and glial cells expressing mutant
HSPB8 did not exhibit any obvious morphological phenotype.
Figure 6. Apoptosis analysis of motor neurons expressing mutant HSPB8. Rat motor neurons were transduced with pLenti-GFP, pLenti-WT-HSPB8-GFP or
mutant pLenti-K141N/K141E-HSPB8-GFP constructs at DIV3 and analyzed for the activation of apoptosis at DIV7 with the TUNEL assay which detects
DNA breaks in the nuclei of apoptotic cells. Confocal micrographs are shown of GFP expression (green in merge), nuclei of all cells (apoptotic and non-
apoptotic, DAPI, blue in merge) and nuclei of apoptotic cells (TUNEL, red in merge). Treating the motor neuron cultures with 50 mM etoposide for 2 h was
used as a positive control for cell death activation (A). Expression of the different constructs did not lead to detectable TUNEL staining (B–E). An additional
internal positive control was provided by the TUNEL-positive nuclei resulting from dead cells always present in the primary cultures (arrowheads). Motor
neurons expressing mutant K141E-HSPB8-GFP exhibit beaded or shortened neurites, but do not have TUNEL-positive nuclei (E). Arrowheads indicate TUNEL-
positive cells and arrows indicate GFP or HSPB8-positive TUNEL-negative cells. Scale bar ¼ 10 mm.
3260 Human Molecular Genetics, 2010, Vol. 19, No. 16This indicates that although the brunt of the injury in motor
neuropathies falls on the motor neurons there might also be
some minor sensory involvement. These observations are com-
patible with the clinical ﬁndings in distal HMN patients in
whom motor nerves are more affected than sensory nerves
and no cognitive impairment is found. The clinical presentation
of both mutations is not overtly different. Patients bearing
the K141N or K141E mutations have been associated with
either a predominant motor neuropathy with very mild
sensory disturbance (distal HMN type II) or a motor and
sensory neuropathy (CMT2L) (7–9). In silico programs pre-
dicting the pathogenicity of mutation could not predict which
mutation is severer; it is likely that the disease in these
CMT2 families represents a phenotypic variant of the clinical
continuum associated with a-crystallin mutations and that a
diagnosis of CMT2 rather than distal HMN was prompted by
the presence of more pronounced sensory symptoms (27).
However, while our experimental ﬁndings appear to support
the clinical ﬁndings, we cannot deny the fact that motor
neurons in culture appear to be much more vulnerable to
environmental stress than the other neuronal cells used in
this study. Therefore, we cannot exclude the possibility that
the motor neuron-speciﬁc phenotype we observed reﬂects
the sensitivity of motor neurons in culture rather than that it
recapitulates the disease phenotype. Still, we rarely observed
degenerated or shortened neurites in WT-HSPB8 expressing
motor neurons, clearly showing the toxicity of HSPB8
mutations to motor neurons.
Though a lot is known about motor neuron function in
health and disease, there are still no obvious explanations
found for the selective motor neuron vulnerability. A charac-
teristic that separates peripheral nerves from other cells is
their peculiar morphology (28). The axons of lower motor
neurons (up to 1 m long) run in peripheral nerves and termi-
nate at neuromuscular junctions of innervated muscles. This
size demands a high metabolic load and precise connectivity
on the normal sized cell body, and may be particularly vulner-
able to free radical-mediated injury (17,28,29). Although
Figure 7. Expression of mutant HSPB8 does not result in increased activation of apoptosis in different neuronal and non-neuronal cell types. Activation of
enzymes implicated in initiation and execution of apoptosis was examined by western blot of cleaved (17, 19 kDa) and total caspase 3 (35 kDa), cleaved
(35, 37 kDa) and total caspase 9 (47 kDa) and cleaved (89 kDa) and total PARP (116 kDa) in different cell types. Stimulation with etoposide (4 h in
50 mM) was used as a positive control for apoptosis activation in the human neuronal cell line SH-SY5Y stably expressing GFP, WT-HSPB8-V5 or mutant
K141N/K141E-HSPB8-V5 constructs (A), in rat primary motor neurons (B) and in rat primary glial cells (C) transduced with pLenti-GFP,
pLenti-WT-HSPB8-GFP or mutant pLenti-K141N/K141E-HSPB8-GFP constructs. Expression of mutant HSPB8 did not result in increased basal levels or in
increased activation after etoposide treatment of the markers for apoptosis. Normalization was performed with b-actin.
Human Molecular Genetics, 2010, Vol. 19, No. 16 3261motor and sensory neurons share a similar morphology, the
mechanisms that cause more severe motor neuron—and to a
lesser extent—sensory neuron degeneration, is unknown.
Several susceptibility factors might be implicated in motor
neuron cell death speciﬁcity, including: differences in
subtype transmitter metabolism, variations in subtype
connectivity, the size of the neuron, variations in glial environ-
ment homeostasis, availability of blood supply in speciﬁc
regions, environmental toxins, differences in mitochondrial
metabolism and sensitivity to oxidative stress, neuroﬁlament
alterations, and differences in gene expression. These suscep-
tibility factors may increase the vulnerability of motor neuron
viability during disease.
Apoptotic cell death is the predominant form of cell loss in
many neurodegenerative diseases (18). We studied the signiﬁ-
cance of HSPB8 mediated cell death in primary glial cells
and neuronal cultures. Surprisingly, no signs of apoptosis
could be detected in any of the cells tested upon expression
of either WT or mutant HSPB8. Even motor neurons that
showed strong features of neurite degeneration appeared to
be TUNEL negative, showing that the two phenomena
occur independently, at least at this stage. In support of our
data, it has been reported before that axon degeneration is
an independent process, which often precedes the death of
the cell body (30) and that axonal pathology rather than
neuronal cell death could be the problem in peripheral
neuropathies (16,30,31). Nonetheless, we cannot exclude the
possibility that over prolonged time periods subtle neurotoxic
mutations in the patients could result in loss of ventral
horn motor neurons and could contribute to the ultimate
progression of the disease.
It is known that axonal spheroids (beaded neurites) and end
bulbs (shortened neurites) may develop after focal blockages
of axonal transport. In support of this theory, we found that
motor neurons expressing mutant HSPB8 showed approxi-
mately a 13% increase in APP accumulation in neurites com-
pared with WT-HSPB8 neurites. Neurite degeneration is often
accompanied by minor swelling of axons (varicosities, less
than 10 mm) that later increase in size (10–50 mm) to form
axonal spheroids (16), very similar to what we observed.
Spheroids are often ﬁlled with a disorganized cytoskeleton
and organelles, and many stain positively for APP (16). As
the spheroids grow, axonal transport may become increasingly
impaired, and this sequence of events could eventually trigger
a phenomenon similar to Wallerian degeneration of the distal
axon, resulting in an end bulb (16). Our data further support
the hypothesis that dying back axon degeneration pathologies,
as in peripheral neuropathies, seem to bear strong similarities
to Wallerian-like degeneration in that both show blockages in
axonal transport and distal neurite degeneration without any
link to apoptosis (16,31–34).
In conclusion, we demonstrated that mutant HSPB8 signiﬁ-
cantly affects motor neurons, and mildly affects sensory
neuronswhileleavingcorticalneuronsandglialcellsunaffected.
Our data support the clinical descriptions of distal HMN type II
implying that mutant HSPB8 could cause defects in preserving
speciﬁcally motor neuron axons. Our future experiments will
be focused on elucidating the precise mechanism how mutant
HSPB8 induces neurite degeneration using disease models,
with the goal of ameliorating the disease phenotype.
MATERIALS AND METHODS
All animal experiments were approved by the University of
Antwerp ethics committee and conducted according to the
guidelines of the Federation of European Laboratory Animal
Science Associations (FELASA).
Isolation of primary cell cultures
Motor neuron-enriched spinal cultures were maintained as
described previously (35,36). Brieﬂy, spinal cords were dis-
sected from E13/E14-day-old Wistar rat embryos. The spinal
cords were stripped of meninges and DRG and separated into
ventral and dorsal halves. The ventral cords were cut into
pieces and dissociated by trypsin treatment and by trituration.
Culturing the cells at this stage without any further puriﬁcation
generates a mixed culture, consisting of motor neurons, inter-
neurons and glial cells (data not shown). A motor neuron-
enriched neuronal population was obtained by centrifugation
on a 6.2% iodixanol OptiPrep cushion separating the glial
cells and smaller neurons from the larger motor neurons. In
this study, we used monocultures which were prepared by
seedingmotorneuronorglialcellson1.5 mg/mlpoly-L-ornithine
or 500 mg/ml poly-L-lysine and 3 mg/ml laminin (Sigma)
coated cover glasses or culture dishes. Motor neurons were
allowed to recover for 3 days in complete neurobasal medium
(NB) supplemented with 2% B27, 4g/L D-glucose, 2 mM
L-glutamine and 50 ng/ml nerve growth factor, 100 mg/ml
penicillin–streptomycin and 2% fetal calf serum (FCS) before
transduction. Glial cells were grown in L15 medium sup-
plemented with 3.6 mg/ml D-glucose, 1% glutamax and
100 mg/ml penicillin–streptomycin, 0.2% sodium bicarbonate
and 10% FCS. Since the motor neuron monoculture was sensi-
tive to environmental stress, we did not include the mitotic
inhibitor 5-ﬂuoro-2′-deoxyuridine and uridine (FUDR, Sigma)
in the culture medium to reduce the number of proliferating
cells. Neuroﬁlament heavy antibody SMI32 and the specialized
morphologyofmotorneurons[neuronalcellswithlargepyrami-
dal soma (diameter . 25 mm) which have more than two neur-
ites] were used to discriminate motor neurons from other cells
types during quantiﬁcation of all experiments.
SensoryneuronswereisolatedfromDRGsfromE13C57BL6
mouse embryos as described previously (37). Brieﬂy, embryos
were isolated from the uterine horns of pregnant mice. The
spinal cords were dissected and DRGs were carefully
removed. DRGs were enzymatically and mechanically disso-
ciated and cells were seeded on 1 mg/ml poly-L-lysine and
3 mg/ml laminin coated culture dishes or cover glasses, and
maintained in complete NB medium. During the ﬁrst days of
culturing, a co-culture of sensory neurons, ﬁbroblasts and a
small number of satellite cells were observed. To obtain pure
sensoryneuroncultures, cycling every2daysbetween thecom-
plete NB medium and the complete NB medium enriched with
1% (v/v) FUDR (ﬁnal 10 mM FdU and 10 mM uridine) was
necessary to kill rapidly dividing cells.
To obtain cortical neuron cultures, C57BL6 mouse E15
embryos were removed from the placenta and placed in a Petri
dish containing Hank’s Buffered Salt Solution and Hepes.
Brains were dissected and the meninges were removed. Mixed
cultures of cortical neurons were made from trypsinized brains
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triturationandplatedinminimumessentialmedium(MEM)sup-
plementedwith10%heat-inactivatedhorseserum.Neuronswere
grown on cell culture dishes and cover glasses that were pre-
coatedwith1 mg/mlpoly-L-lysineand3 mg/mllaminin.Cortical
neurons were allowed to attach in MEM medium for 24 h and
subsequently grown in complete NB medium.
Lentiviral transduction
Transduction was performed using the pLenti6/V5-DEST
vectors (Invitrogen) containing the human CMV immediate
early promoter. The destination vectors are adapted for use
withtheGateway
wTechnology,andaredesignedtoallowhigh-
level expression of recombinant fusion proteins in dividing and
non-dividing mammalian cells using a replication-incompetent
lentivirus. WT and mutant HSPB8-GFP fusion constructs were
PCR ampliﬁed with proof reading enzymes and gateway entry
and expression clones were created in the pLenti6-DEST
vectors. All constructs were sequence veriﬁed. Lentivirus
encoding HSPB8-GFP WT and mutant fusion constructs were
produced in HEK293T cells by cotransfection of 10 mgo f
pLenti-HSPB8 expression constructs together with 3 mgo f
pMD2-VSV and 6.5 mg of pCMV-R8.91 viral packaging
vectors for lentivirus using the calcium phosphate transfection
method. After 8 h of transfection, the calcium transfection
medium was removed, the cells were washed with PBS and
replaced with medium containing 10 mM sodium butyrate to
enhance promoter activity. The next day the medium was
replacedwith8 mlcompleteNBmediumandlentiviruswaspro-
duced for 24 h. The produced lentivirus was harvested by ﬁlter-
ing the supernatant of the HEK293T cells. We used 1000
lentiviral particles per cell to transduce the primary cells
seeded on culture dishes or cover glasses. GFP ﬂuorescence
was visible in transduced cells after 3–4 days. The transduction
efﬁciency of the primary cells was over 70%.
Generation of SH-SY5Y stable cell lines expressing HSPB8
To generate stable SH-SY5Y cell lines, we made constructs
encoding different HSPB8 mutations or EGFP using the
Gateway recombination system (Invitrogen). Using primers
containing the attB recombination sites, open reading frames
(ORFs) from HSPB8 WT, K141N and K141E were ampliﬁed
from constructs described elsewhere (5). The EGFP cassette
was ampliﬁed from pEGFP-N1 (Clontech). The PCR products
containing the ORFs ﬂanked by the attB recombination sites
were then recombined into a pDONR221 vector and sequence
validated. The validated pDONRs-HSPB8 constructs were
then transferred by recombination to the pLENTI6/V5-Dest
(Invitrogen) generating constructs with the ORFs C-terminally
fused to a V5-tag. Stable cell lines were produced by lentiviral
transduction of the neuronal cell line SH-SY5Y, according to
the method described by Salmon and Trono (39).
After infection, the cells were selected in MEM media sup-
plemented with 10% FCS, 1% non-essential amino acids,
2m M glutamine and 100 mg/ml penicillin/streptomycin and
blasticidin (3 mg/ml) for 3–4 weeks. The whole population
of selected cells was pooled for further experiments. After
selection, cells were cultured in MEM medium supplemented
with 10% fetal bovine serum and blasticidin (3 mg/ml). Stable
cell lines showed similar expression levels of the HSPB8 gene
by western blot.
Immunocytochemistry and microscopy experiments
Cells were ﬁxed in 3% paraformaldehyde using standard pro-
tocols (5). We tested several established motor neuronal
markers including the choline acetyl transferase (ChAT),
beta-3 tubulin, the non-phosphorylated neuroﬁlament heavy
isoform (SMI32) and 75 kDa low-afﬁnity neurotrophin recep-
tor (p75NTR). We found that SMI32 and beta-3 tubulin
speciﬁcally labeled neuronal cells and gave the best results
in our hands. SMI32 neuroﬁlament antibody is a well-
established motor neuron marker (40,41).
Immunostaining was performed with the following glial or
neuronal antibodies and dilutions: GFAP (1/1000, Chemicon
International), Schwann cell/oligodendrocyte marker 2′,3′-cyclic
nucleotide 3′-phosphodiesterase (CNPase, 1/200, Abcam), non-
phosphorylated epitope in neuroﬁlament H (SMI32, 1/1000,
Sternberger monoclonals), neuron speciﬁc beta III tubulin (b-III
tubulin, 1/500, Abcam) and APP antibody (APPC20/2, I/1000,
custom made by Sigma).Alexa Fluor 594 antibodies (Invitrogen)
were used as secondary antibodies for ﬂuorescence detection.
Dapi or Hoechst 33342 (1/20000, Invitrogen) was used to stain
the nucleus. Cells were microscopically examined and images
were acquired by the use of different (confocal) microscopes:
Zeiss Axiovert 200 with apotome technology (60X 1.4
NA-objective; GFP detection: BP 500/20, FT 515, BP 535/30;
AF555, AF594 and TUNEL detection: BP 545/25, FT 570, BP
605/70; DAPI detection: G 365, FT 395, BP 445/50), Zeiss
LSM700 (60X 1.4 NA-objective; 405, 488, 514 nm solid state
lasers and variable secondary dichroic technology) and Zeiss
LSM510 (60X 1.4 NA-objective) confocal microscope equipped
withanArgon(488 nm),twoHelium/Neon(543and633 nm)and
a tunable Titan/sapphire laser (700–1000 nm). Images were pro-
cessed with the AxioVision, LSM510 or Zen 2008 browser soft-
ware (Zeiss), ImageJ (42) and CorelDraw (http://www.pcpro.co.
uk/reviews/software/158352/coreldraw-graphics-suite-x4).
Detection of DNA strand breaks in cultured cells
To detect apoptotic cell death in individual cells, primary
neurons and glial cells were ﬁxed with 3% formaldehyde in
PBS and DNA fragmentation in nuclei of cells in apoptosis
was stained by use of a TUNEL detection assay. We used
the In Situ Cell Death Detection Kit (TMR red, Roche) accord-
ing to the manufacturer’s protocol. Brieﬂy, the assay measures
and quantiﬁes apoptotic cell death by labeling and detection of
DNA strand breaks in individual cells by ﬂow cytometry or
ﬂuorescence microscopy. Cells were incubated with the
TUNEL reaction mixture containing TdT and TMR-dUTP.
During an incubation step, TdT catalyzes the attachment of
TMR-dUTP to free 3′OH ends in the DNA.
Western blotting
Cells were lysed in NP40 lysis buffer (250 mM NaCl, 1 mM
EDTA, 20 mM HEPES pH 7.9, 1% NP40, 20 mM b-
glycerophosphate, 10 mM Sodium ﬂuoride, 4 mM Sodium
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DDT) supplemented with protease inhibitor cocktail (Roche)
for 20 min on ice and cleared by centrifugation. When the
number of neurons was limited, we directly lysed cells on
plate with 1x NuPage sample buffer (Invitrogen, 5X NuPage
sample buffer ¼ 250 mM Tris–HCl pH 6.8, 10% SDS, 30%
Glycerol, 0.02% bromophenol blue, supplemented with
100 mM DTT), followed by sonication. Cell extracts were
boiled for 5 min and equal concentrations of cell lysates
were resolved on a SDS-NuPage gel. The gel was transferred
to nitrocellulose membrane and processed for western blotting
as described previously (5,43). For analysis of apoptosis, we
used: cleaved caspase 3, total caspase 3, cleaved caspase 9,
total caspase 9, cleaved PARP and total PARP (all antibodies
were obtained from Cell Signalling and used at 1/1000
dilution). For the analysis of protein expression, we used com-
mercial available monoclonal HSPB8 antibodies: clone 2H5
(Abcam, cat. no. ab15896, no longer commercially available,
1/2000), GFP antibody JL8 (Clontech, 1/5000), anti-V5 anti-
body (Invitrogen, 1/5000) and anti-b-Actin (Sigma, 1/5000).
Quantiﬁcation of neurite degeneration and statistical
analysis
Data showing incidence of events in neuronal cells (neurite
degeneration, reduction of neurite length, strong APP
accumulation) were expressed as mean percentages+stan-
dard deviation, after counting multiple random regions from
three independent experiments. Cell counts were done
blinded and all experiments were repeated independently.
Statistical comparison was done by using Student’s t-test.
Cells were deﬁned to have reduced neurite length if the
neurites did not extend a 40× microscopic ﬁeld of view.
For the data presented in Fig. 1F, the number of counted
motor neurons is n ¼ 361 for GFP, n ¼ 192 for HSPB8-WT,
n ¼ 150 for HSPB8-K141N and n ¼ 300 for HSPB8-K141E.
In the assay in which the proportion of cells with beaded neur-
ites was counted (Fig. 1G), the number of counted motor
neurons was n ¼ 338 for GFP, n ¼ 192 for HSPB8-WT, n ¼
150 for HSPB8-K141N and n ¼ 300 for HSPB8-K141E. In
each image mosaiX, the longest neurite length per cell was
measured by use of the Zeiss Axiovert 200 measurement
tool software and the distribution of neurite lengths was rep-
resented as the percentage of neurons with a neurite length
longer than the neurite length being measured (abscissa),
also referred to as a ‘Chang plot’ (44). For the presented
data in Figure 1H, the number of measured neurites was n ¼
74 for GFP, n ¼ 61 for HSPB8-WT, n ¼ 30 for
HSPB8-K141N and n ¼ 47 for HSPB8-K141E. For average
neurite number quantiﬁcation: n ¼ 248 for GFP, n ¼ 219 for
HSPB8-WT, n ¼ 428 for HSPB8-K141N and n ¼ 424 for
HSPB8-K141E (Fig. 1I). The number of counted sensory
neurons (beaded neurite phenotype quantiﬁcation) was n ¼
655 for GFP, n ¼ 436 for HSPB8-WT, n ¼ 578 for
HSPB8-K141N and n ¼ 660 for K141E (Fig. 4E). The inci-
dence of APP accumulation was quantiﬁed by randomly
counting the proportion of cells with and without strong neuri-
tic APP accumulation. The number of counted motor neuron
neurites was n ¼ 994 for GFP, n ¼ 971 for HSPB8-WT, n ¼
864 for HSPB8-K141N and n ¼ 1029 for HSPB8-K141E.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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